Amanote Research
Register
Sign In
Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-1085
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 1, 2005
Authors
J. Zhou
Publisher
American Association for Cancer Research (AACR)
Related search
A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent
Oncogene
Cancer Research
Genetics
Molecular Biology
Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
PLK1 (Polo-Like Kinase 1 (Drosophila))
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
pH-sensitive Oncolytic Adenovirus Hybrid Targeting Acidic Tumor Microenvironment and Angiogenesis
Journal of Controlled Release
Pharmaceutical Science
Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma
Lymphoma
A Novel Treatment Strategy Targeting Polo-Like Kinase 1 in Hematological Malignancies
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Hepatocellular Carcinoma-Targeting Oncolytic Adenovirus Overcomes Hypoxic Tumor Microenvironment and Effectively Disperses Through Both Central and Peripheral Tumor Regions
Scientific Reports
Multidisciplinary
Bioorthogonal Probes for Polo-Like Kinase 1 Imaging and Quantification
Angewandte Chemie
In Vitro Study of the Polo-Like Kinase 1 Inhibitor Volasertib in Non-Small Cell Lung Cancer Reveals a Role for the Tumor Suppressor P53
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
